Weight Loss
14
 min read

Does Zyprexa Cause Man Boobs? Olanzapine Guide

Written by
Bolt Pharmacy
Published
9/10/2026
Last Updated

Zyprexa (olanzapine) and gynaecomastia (enlarged breast tissue in men) are linked through the medicine's effects on hormone regulation, particularly its ability to raise prolactin levels. Men taking olanzapine sometimes notice breast swelling, tenderness or nipple discharge, which can be distressing and confusing. This article explains why olanzapine can cause breast changes, how common this side effect is, what other side effects men should watch for, and what practical steps to take if you notice any breast changes while on this medication.

Summary: Zyprexa (olanzapine) can cause gynaecomastia in men, primarily by raising prolactin levels through dopamine D2 receptor blockade, and this is listed as an uncommon but recognised side effect in the olanzapine SmPC.

  • Olanzapine raises prolactin by blocking dopamine D2 receptors, reducing dopamine's inhibitory effect on the pituitary gland, which can stimulate breast tissue growth in men.
  • Gynaecomastia and related breast symptoms are classified as uncommon side effects, estimated to affect between 1 in 100 and 1 in 1,000 people taking olanzapine.
  • Weight gain associated with olanzapine can independently contribute to breast enlargement through increased oestrogen production in fatty tissue.
  • Men should not stop olanzapine without medical supervision; abrupt discontinuation carries significant psychiatric risks.
  • Hard or irregular lumps, nipple inversion, skin changes or blood-stained nipple discharge require prompt GP review and possible referral via the NICE NG12 suspected cancer pathway.
  • Management options include dose reduction, switching to a lower-prolactin antipsychotic such as quetiapine or aripiprazole, or adding low-dose aripiprazole alongside existing treatment.

Can Zyprexa cause gynaecomastia (enlarged breast tissue in men)?

Yes, Zyprexa (olanzapine) can cause gynaecomastia; it is listed as a known side effect in the olanzapine SmPC and has been reported in both clinical trials and post-marketing surveillance.

Yes, Zyprexa (olanzapine) can cause gynaecomastia, which is the development of enlarged or swollen breast tissue in men. Gynaecomastia is listed as a known side effect in the olanzapine Summary of Product Characteristics (SmPC), published on the MHRA/EMC, and cases have been reported both during clinical trials and in post-marketing surveillance.[1][2] It is important to understand that gynaecomastia in this context refers to actual glandular breast tissue growth, rather than fat accumulation, although both can occur with olanzapine for different reasons.

Olanzapine belongs to a class of medicines called atypical antipsychotics. These medicines work on multiple receptor systems in the brain, and some of their effects on hormone regulation can lead to physical changes including breast tissue development in men. Breast enlargement caused by medication is usually benign, but it can cause discomfort, tenderness and psychological distress, and it is always worth discussing with a healthcare professional if it occurs.

It is important to be aware that not all breast changes in men are caused by medication. Gynaecomastia can also result from natural hormonal fluctuations, obesity, liver conditions and other medicines. More rarely, breast changes in men can be a sign of male breast cancer. Red flags that warrant prompt medical review include a hard or irregular lump (particularly if one-sided), nipple inversion, skin changes over the breast, or any nipple discharge, especially if blood-stained. If you notice any of these features, contact your GP promptly; they can refer you through the appropriate pathway if needed, including the NICE NG12 suspected cancer referral route where indicated.

A GP can help determine whether olanzapine is the likely cause of breast changes or whether further investigation is needed. Men who notice any breast changes while taking Zyprexa should not stop their medication without first speaking to their prescribing doctor, as abrupt discontinuation of antipsychotic treatment carries its own risks.

Side Effect Frequency Severity Management
Gynaecomastia (enlarged breast tissue) Uncommon (1 in 100 to 1 in 1,000) Mild to moderate; can cause discomfort and psychological distress Discuss with GP or psychiatrist; prolactin blood test; consider dose reduction or switch to quetiapine or aripiprazole
Hyperprolactinaemia (raised prolactin) Uncommon; subclinical elevation may be more frequent Mild to moderate; may not cause obvious symptoms Serum prolactin measurement; review antipsychotic; low-dose aripiprazole add-on is a recognised option per Maudsley Guidelines
Nipple discharge (galactorrhoea) Uncommon Moderate; blood-stained discharge requires urgent GP review Report promptly to GP; blood-stained discharge may warrant NICE NG12 suspected cancer referral
Weight gain and increased appetite Very common Moderate to severe; increases risk of type 2 diabetes and cardiovascular disease Regular monitoring of weight, blood glucose (HbA1c) and lipids per NICE and BNF guidance; dietitian referral if needed
Raised blood glucose and lipids Common Moderate to severe; risk of hyperglycaemia Routine monitoring recommended; excessive thirst, polyuria or confusion require urgent assessment
Sedation and fatigue Common, especially early in treatment Mild to moderate Avoid driving or operating machinery until effect is known; review dose timing with prescriber
Neuroleptic malignant syndrome (NMS) Rare Potentially life-threatening High fever, severe muscle rigidity and confusion require immediate 999 call or attendance at accident and emergency

Why does olanzapine affect hormone levels in some men?

Olanzapine raises prolactin by blocking dopamine D2 receptors, reducing dopamine's inhibitory control over the pituitary gland; significant weight gain can also increase oestrogen production, further contributing to breast enlargement.

Olanzapine can cause gynaecomastia primarily by raising levels of a hormone called prolactin, a process known as hyperprolactinaemia. Prolactin is produced by the pituitary gland and is normally kept in check by dopamine. Olanzapine blocks dopamine D2 receptors in the brain, which reduces dopamine's inhibitory effect on the pituitary gland, allowing prolactin levels to rise.[14][16] Elevated prolactin can stimulate breast tissue growth in men and may also cause nipple discharge (galactorrhoea), reduced libido and other hormonal effects.

Compared with some other antipsychotics, olanzapine tends to cause smaller prolactin elevations than older typical antipsychotics such as haloperidol, or agents such as risperidone and amisulpride, though the effect is still clinically significant in some individuals.[13][14] The degree of prolactin rise varies considerably between people and does not always correlate directly with the severity of physical symptoms. The BNF and the olanzapine SmPC both note endocrine effects, including hyperprolactinaemia, as recognised adverse reactions.[1][2]

Beyond prolactin, olanzapine is associated with significant weight gain, which can independently contribute to breast enlargement through increased fatty tissue and peripheral conversion of androgens to oestrogens in adipose tissue.[16][15] This means that some men on olanzapine may experience breast enlargement through hormonal mechanisms, through weight gain, or through a combination of both.

It is also important to consider other possible causes of raised prolactin, including pituitary conditions and other prolactin-raising medicines a person may be taking. A GP or psychiatrist can arrange appropriate blood tests, including a serum prolactin measurement, to help clarify the underlying cause. Understanding the cause matters because it influences how the issue is best managed.

How common is breast swelling or tenderness on Zyprexa?

Gynaecomastia and breast tenderness are classified as uncommon side effects of olanzapine, estimated to affect between 1 in 100 and 1 in 1,000 people taking the medicine.

According to the olanzapine SmPC (MHRA/EMC), gynaecomastia and related breast symptoms such as tenderness or nipple discharge are classified as uncommon side effects, meaning they are estimated to affect between 1 in 100 and 1 in 1,000 people taking the medicine. Hyperprolactinaemia (raised prolactin) is also listed as an uncommon adverse reaction in the SmPC.[2][1] Subclinical prolactin elevation without obvious physical symptoms may occur more frequently than overt breast changes, and not all men who develop elevated prolactin will go on to develop noticeable breast tissue enlargement.

The risk appears to be influenced by several factors, including the dose of olanzapine, the duration of treatment, individual sensitivity to prolactin changes, body weight and baseline hormone levels. Men who gain significant weight on olanzapine may be at greater risk of breast enlargement through the additional mechanism of increased oestrogen production in fatty tissue.

People taking antipsychotics such as olanzapine are recommended to have regular physical health monitoring, including checks of weight, blood glucose or HbA1c, blood lipids and blood pressure, in line with NICE and BNF guidance on antipsychotic treatment.[10][11] Where breast symptoms or other signs of hormonal change are present, prolactin measurement may also be appropriate. If you are taking olanzapine and have noticed any breast changes, even mild ones, it is appropriate to mention this at your next appointment. Your doctor will not be surprised by the question, and there are practical steps that can be taken to assess and manage the symptom without necessarily changing your psychiatric treatment.

What side effects should men watch for when taking olanzapine?

Men on olanzapine should monitor for weight gain, raised blood glucose and lipids, sedation, postural dizziness, hormonal effects such as gynaecomastia, and rarely neuroleptic malignant syndrome, which requires emergency care.

Men taking olanzapine should be aware of a range of potential side effects beyond breast changes, so that they can report anything concerning to their doctor promptly. The most commonly reported side effects include:

  • Weight gain and increased appetite: Olanzapine is one of the antipsychotics most strongly associated with significant weight gain, which can increase the risk of type 2 diabetes and cardiovascular problems over time.[4][15]

  • Raised blood glucose and lipids: Olanzapine can affect glucose metabolism and cholesterol levels, so regular monitoring is recommended in line with NICE and BNF guidance.[9][8]

  • Sedation and fatigue: Feeling drowsy, particularly in the early weeks of treatment, is common. This can affect your ability to drive or operate machinery, and you should follow your doctor's advice on this.

  • Dizziness on standing (postural hypotension): This can increase the risk of falls, particularly in older men.

  • Hormonal effects: As discussed, these include raised prolactin, which may cause breast tenderness, gynaecomastia, nipple discharge or reduced libido and sexual function.

  • Movement-related effects (extrapyramidal symptoms): Although less common with olanzapine than with older antipsychotics, restlessness, stiffness or tremor can occasionally occur.

There are some serious but uncommon reactions associated with olanzapine that require urgent medical attention. Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening reaction characterised by high fever, severe muscle rigidity, confusion and changes in consciousness.[22][23] If you or someone with you develops these symptoms, call 999 or go to your nearest accident and emergency department immediately. Olanzapine can also cause significant rises in blood glucose; symptoms of severe hyperglycaemia include excessive thirst, passing large amounts of urine, and unusual drowsiness or confusion, and these also require urgent assessment. Signs of a serious allergic reaction, such as facial swelling, difficulty breathing or swallowing, are likewise a medical emergency requiring 999.

Suspected side effects can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

What can you do if you notice breast changes while on Zyprexa?

Speak to your GP or prescribing psychiatrist rather than stopping olanzapine yourself; they can check prolactin levels and consider dose reduction, switching antipsychotic, or adding aripiprazole to manage hyperprolactinaemia.

If you notice breast swelling, tenderness or nipple discharge while taking Zyprexa, the most important first step is to speak to your GP or prescribing psychiatrist rather than stopping the medication on your own. Abruptly discontinuing olanzapine can lead to a return of psychiatric symptoms and should only be done under medical supervision.

If you notice a hard or irregular lump (particularly on one side), nipple inversion, skin changes over the breast, or blood-stained nipple discharge, contact your GP promptly rather than waiting for a routine appointment. These features may warrant referral through the NICE NG12 suspected cancer pathway to rule out male breast cancer, even though this is uncommon.

For breast changes that appear to be medication-related, your doctor is likely to take a clinical history and may arrange a blood test to measure serum prolactin levels. If prolactin is significantly elevated, they will consider whether the dose of olanzapine can be reduced, or whether switching to an antipsychotic with a lower propensity to raise prolactin (such as quetiapine or aripiprazole) is appropriate given your overall psychiatric needs.[20][14] Where switching is not desirable, adding low-dose aripiprazole alongside the existing antipsychotic is a recognised option for managing antipsychotic-induced hyperprolactinaemia, as described in the Maudsley Prescribing Guidelines in Psychiatry.[19][21] Any change in antipsychotic treatment requires careful planning and monitoring, and the decision will always balance the benefits of your current medication against the side effects you are experiencing.

If weight gain is contributing to breast enlargement, your doctor may refer you to a dietitian or a structured weight management programme. In some cases, where gynaecomastia is persistent and causing significant distress, a referral to an endocrinologist or a breast surgeon may be considered, though surgical intervention is rarely needed.

It is also worth keeping a simple record of when you first noticed the breast changes, whether they are getting worse, and any associated symptoms such as nipple discharge or pain. This information will help your doctor assess the situation more accurately. Do not feel embarrassed to raise this issue: it is a recognised and manageable side effect, and your clinical team is there to support you.

Scientific References

  1. .
  2. .
  3. .
  4. .
  5. .
  6. .
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .
  13. .
  14. .
  15. .
  16. .
  17. .
  18. .
  19. .
  20. .
  21. .
  22. .
  23. .
  24. .

Frequently Asked Questions

Can olanzapine cause permanent breast tissue growth in men?

In some men, gynaecomastia caused by olanzapine may persist even after the prolactin level normalises, particularly if the breast tissue has been present for a long time. Early identification and management, such as dose reduction or switching antipsychotic, gives the best chance of resolution without surgical intervention.

Should I stop taking Zyprexa if I notice breast swelling?

No, you should not stop taking Zyprexa without speaking to your doctor first, as abrupt discontinuation can cause a return of psychiatric symptoms. Contact your GP or prescribing psychiatrist to discuss the breast changes and explore appropriate management options.

Which antipsychotics are less likely to cause gynaecomastia than olanzapine?

Quetiapine and aripiprazole have a lower propensity to raise prolactin and are recognised alternatives for people experiencing antipsychotic-induced hyperprolactinaemia. Any switch in antipsychotic medication must be planned carefully with your psychiatrist to balance psychiatric stability against side effects.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.